Stock comparison
ARGENX SE is 5.1x more valuable than QIAGEN N.V. by market capitalization ($56.15 B vs $10.93 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ARGX is larger
ARGENX SE is 5.1x more valuable than QIAGEN N.V. by market capitalization ($56.15 B vs $10.93 B).
Market value leader
ARGX
ARGENX SE is 5.1x more valuable than QIAGEN N.V. by market capitalization ($56.15 B vs $10.93 B).
| Metric | QGEN | ARGX |
|---|---|---|
| Market cap | $10.93 B | $56.15 B |
| US-listed rank | #881 | #294 |
| Revenue (latest FY) | $2.09B | - |
| Net income (latest FY) | $424.88M | - |
| Net margin | 20.3% | - |
| P/E (trailing FY) | 25.7x | - |
| SEC filings | 471 | 272 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ARGENX SE is 5.1x more valuable than QIAGEN N.V. by market capitalization ($56.15 B vs $10.93 B).
Full pages: QIAGEN N.V. and ARGENX SE, or browse the full rankings.